Patent holdings for IPC class A61P 3/00

Total number of patents in this class: 7019

10-year publication summary

258
242
392
467
471
564
511
525
493
207
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Mondobiotech Laboratories AG
311
282
F. Hoffmann-La Roche AG
7920
66
Bristol-myers Squibb Company
4897
59
Boehringer Ingelheim International GmbH
4701
56
Takeda Pharmaceutical Company Limited
2703
56
Janssen Pharmaceutica N.V.
3432
54
Novartis AG
10927
47
Amicus Therapeutics, Inc.
350
45
The Trustees of the University of Pennsylvania
4304
41
Modernatx, Inc.
1258
40
Société des Produits Nestlé S.A.
9190
39
Regeneron Pharmaceuticals, Inc.
4223
38
Pfizer Inc.
3358
37
Eli Lilly and Company
3809
37
University of Pittsburgh - Of the Commonwealth System of Higher Education
3123
33
sanofi-aventis
377
33
Amgen Inc.
4037
32
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
820
32
The Regents of the University of California
19803
30
Genzyme Corporation
1233
30
Other owners 5932